{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T06:02:16Z","timestamp":1705212136492},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1983,12,1]],"date-time":"1983-12-01T00:00:00Z","timestamp":439084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1983,12,1]],"date-time":"1983-12-01T00:00:00Z","timestamp":439084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1983,12]]},"DOI":"10.1007\/bf00177414","type":"journal-article","created":{"date-parts":[[2004,8,21]],"date-time":"2004-08-21T12:41:41Z","timestamp":1093092101000},"page":"309-313","source":"Crossref","is-referenced-by-count":16,"title":["Phase I trial with 4\u2032-deoxydoxorubicin (esorubicin)"],"prefix":"10.1007","volume":"1","author":[{"given":"Marcel","family":"Rozencweig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Crespeigne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvon","family":"Kenis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00177414_CR1","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/jm00234a016","volume":"19","author":"F Arcamone","year":"1976","unstructured":"Arcamone F, Penco S, Redaelli S, Hanessian S: Synthesis and antitumor activity of 4\u2032-deoxydaunorubicin and 4\u2032-deoxyadriamycin. J Med Chem 19:1424\u20131425, 1976","journal-title":"J Med Chem"},{"key":"BF00177414_CR2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0277-5379(83)90140-2","volume":"19","author":"AM Casazza","year":"1983","unstructured":"Casazza AM, Savi G, Pratesi G, Di Marco A: Antitumor activity in mice of 4\u2032-deoxydoxorubicin in comparison with doxorubicin. Eur J Cancer Clin Oncol 19:411\u2013418, 1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF00177414_CR3","first-page":"4682","volume":"40","author":"FC Giuliani","year":"1980","unstructured":"Giuliani FC, Kaplan NO: New doxorubicin analogs active against doxorubicin-resistant colon tumor xenografts in the nude mouse. Cancer Res 40:4682\u20134687, 1980","journal-title":"Cancer Res"},{"key":"BF00177414_CR4","first-page":"1063","volume":"65","author":"FC Giuliani","year":"1981","unstructured":"Giuliani FC, Coirin AK, Rice MR, Kaplan NO: Effect of 4\u2032-doxorubicin analogs on heterotransplantation of human tumors in congenitally athymic mice. Cancer Treat Rep 65:1063\u20131075, 1981","journal-title":"Cancer Treat Rep"},{"key":"BF00177414_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00262325","volume":"6","author":"SE Salmon","year":"1981","unstructured":"Salmon SE, Liu RM, Casazza AM: Evaluation of new anthracycline analogs with the human tumor stem cell assay. Cancer Chemother Pharmacol 6:103\u2013110, 1981","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF00177414_CR6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0009-2797(77)90052-7","volume":"19","author":"A Di Marco","year":"1977","unstructured":"Di Marco A, Casazza AM, Dasdia T, Necco A, Pratesi G, Rivolta P, Velcich A, Zaccara A, Zunino F: Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moiety. Chem Biol Interact 19:291\u2013302, 1977","journal-title":"Chem Biol Interact"},{"key":"BF00177414_CR7","first-page":"403","volume-title":"Anthracycline: Current Status and New Developments","author":"AM Casazza","year":"1980","unstructured":"Casazza AM, Di Marco A, Bonadonna G, Bonfante V, Bertazzoli C, Bellini O, Pratesi G, Sala L, Ballerini L: Effects of modifications in position 4 of the chromophore or in position 4\u2032 of the amino-sugar, on the antitumor activity and toxicity of daunorubicin and doxorubicin. In ST Crooke and SD Reich (eds): Anthracycline: Current Status and New Developments. Academic Press, New York, 1980, pp 403\u2013430"},{"key":"BF00177414_CR8","first-page":"835","volume":"63","author":"AM Casazza","year":"1979","unstructured":"Casazza AM: Experimental evaluation of anthracycline analogs. Cancer Treat Rep 63:835\u2013844, 1979","journal-title":"Cancer Treat Rep"},{"key":"BF00177414_CR9","volume-title":"4\u2032-deoxydoxorubicin. Clinical Brochure","author":"IMI 58","year":"1981","unstructured":"IMI 58, 4\u2032-deoxydoxorubicin. Clinical Brochure, M. Cagnasso (ed), Farmitalia Carlo Erba, Milan, 1981"},{"key":"BF00177414_CR10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00258470","volume":"5","author":"F Formelli","year":"1981","unstructured":"Formelli F, Pollini C, Casazza AM, di Marco A, Mariani A: Fluorescence assays and pharmacokinetic studies of 4\u2032-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors. Cancer Chemother Pharmacol 5:139\u2013144, 1981","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF00177414_CR11","first-page":"1","volume-title":"New Approaches in Cancer Therapy","author":"M Rozencweig","year":"1982","unstructured":"Rozencweig M, Dodion P, Nicaise C, Piccart M, Kenis Y: Approach to Phase I trials in cancer patients. In H. Cortes Funes and M Rozencweig (eds): New Approaches in Cancer Therapy. Raven Press, New York, 1982, pp 1\u201313"},{"key":"BF00177414_CR12","first-page":"24","volume":"2","author":"C Sessa","year":"1983","unstructured":"Sessa C, Kaplan S, Kaplan E, Varini M, Cavalli F: Phase I trial of i.v. weekly 4\u2032-deoxydoxorubicin. Proc Am Soc Clin Oncol 2:24, 1983","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00177414_CR13","first-page":"21","volume":"4","author":"M Rozencweig","year":"1981","unstructured":"Rozencweig M, Von Hoff DD, Staquet MJ, Schein PS, Penta JS, Goldin A, Muggia FM, Freireich EJ, De Vita VT Jr: Animal toxicology for early clinical trials with anticancer agents. Cancer Clin Trials 4:21\u201328, 1981","journal-title":"Cancer Clin Trials"},{"key":"BF00177414_CR14","volume-title":"Handbook for Reporting Results of Cancer Treatment","author":"WHO","year":"1979","unstructured":"WHO Handbook for Reporting Results of Cancer Treatment. World Health Organization, Geneva, 1979"},{"key":"BF00177414_CR15","first-page":"153","volume":"24","author":"GF Stanton","year":"1983","unstructured":"Stanton GF, Wittes RE, Raymond V, Budman D, Shulman P, Kelsen D, Young CW: 4\u2032-Deoxydoxorubicin (DXDX): a Phase I trial in patients (pts) with advanced cancer. Proc Am Assoc Cancer Res 24:153, 1983","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00177414_CR16","first-page":"163","volume":"24","author":"L Ferrari","year":"1983","unstructured":"Ferrari L, Rossi A, Brambilla C, Villani F, Bonfante V, Bonadonna G: Phase I study with 4\u2032-deoxydoxorubicin (deoxyDX). Proc Am Assoc Cancer Res 24:163, 1983","journal-title":"Proc Am Assoc Cancer Res"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00177414.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00177414\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00177414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00177414.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:24:50Z","timestamp":1678559090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00177414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,12]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1983,12]]}},"alternative-id":["BF00177414"],"URL":"https:\/\/doi.org\/10.1007\/bf00177414","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,12]]}}}